S&P 500   3,224.39 (+0.84%)
DOW   26,823.74 (+0.68%)
QQQ   261.15 (+0.30%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,224.39 (+0.84%)
DOW   26,823.74 (+0.68%)
QQQ   261.15 (+0.30%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,224.39 (+0.84%)
DOW   26,823.74 (+0.68%)
QQQ   261.15 (+0.30%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,224.39 (+0.84%)
DOW   26,823.74 (+0.68%)
QQQ   261.15 (+0.30%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
Log in

OTCMKTS:CRLBFCresco Labs Stock Price, Forecast & News

$5.12
-0.02 (-0.39 %)
(As of 07/15/2020 02:01 PM ET)
Add
Compare
Today's Range
$4.81
Now: $5.12
$5.17
50-Day Range
$4.00
MA: $4.45
$5.10
52-Week Range
$1.94
Now: $5.12
$9.85
Volume476,100 shs
Average Volume610,568 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cresco Labs Inc. cultivates, manufactures, and sells medical cannabis and medical cannabis products in the United States. It offers cannabis in flower, vape pens, and various forms of extracts under the cresco and Reserve brands; precisely-dosed and non-combustible products, including tinctures, capsules, salves, sublingual oils, and transdermal patches under the Remedi brand; culinary-backed and cannabis-infused edibles under the Mindy's Artisanal brand; and fruity confections under the Mindy's Kitchen brand. As of June 12, 2019, it operated 20 dispensaries in Florida. The company is headquartered in Chicago, Illinois.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CRLBF
CUSIPN/A
CIKN/A
Phone312-929-0993

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees1,400
Next Earnings DateN/A
OptionableNot Optionable

Receive CRLBF News and Ratings via Email

Sign-up to receive the latest news and ratings for CRLBF and its competitors with MarketBeat's FREE daily newsletter.

Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions

How has Cresco Labs' stock been impacted by COVID-19 (Coronavirus)?

Cresco Labs' stock was trading at $3.34 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CRLBF shares have increased by 53.3% and is now trading at $5.12. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cresco Labs?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cresco Labs.

What price target have analysts set for CRLBF?

7 equities research analysts have issued 1-year price objectives for Cresco Labs' stock. Their forecasts range from $4.20 to $14.00. On average, they expect Cresco Labs' stock price to reach $10.37 in the next year. This suggests a possible upside of 102.5% from the stock's current price. View analysts' price targets for Cresco Labs.

Has Cresco Labs been receiving favorable news coverage?

News coverage about CRLBF stock has trended negative this week, InfoTrie reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cresco Labs earned a news impact score of -2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news about Cresco Labs.

Who are some of Cresco Labs' key competitors?

Who are Cresco Labs' key executives?

Cresco Labs' management team includes the following people:
  • Mr. Charles Bachtell, Co-Founder, CEO & Director (Age 41)
  • Mr. Brian Thomas McCormack, Co-Founder & Vice-Chairman (Age 51)
  • Mr. Joseph Stevens Caltabiano, Pres, Co-founder & Director (Age 42)
  • Mr. Dominic Anthony Sergi, Co-Founder & Director (Age 36)
  • Mr. Robert M. Sampson, Co-Founder & Director (Age 45)

What is Cresco Labs' stock symbol?

Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."

How do I buy shares of Cresco Labs?

Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cresco Labs' stock price today?

One share of CRLBF stock can currently be purchased for approximately $5.12.

What is Cresco Labs' official website?

The official website for Cresco Labs is www.crescolabs.com.

How can I contact Cresco Labs?

The company can be reached via phone at 312-929-0993.

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.